Erythropoietic Protoporphyria
📧 Sign up to get email alerts when something new happens for Erythropoietic Protoporphyria.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-01-30EMA Authorised: Scenesse (afamelanotide) — Clinuvel Europe Limited
The EMA authorised Scenesse (afamelanotide) for erythropoietic protoporphyria, with Clinuvel Europe Limited as the marketing authorisation h…
-
FDA approval · 2019-10-08FDA Approved: SCENESSE — Original Application (CLINUVEL INC.)
FDA approved SCENESSE (afamelanotide) as the original application for adults with erythropoietic protoporphyria to increase tolerance to sun…